Metabolics Pharma
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Subcutaneously Administered ENT-03 for the Treatment of Obesity and Diabetes (NCT05925920) | Metabolics Pharma | 2023-06-13 |
Track Metabolics Pharma automatically
Every clearance here is in the API, with alerts when new ones post.